Superoxide radical generation from heterocyclic amines. 1995

H Maeda, and K Sato, and T Akaike
Department of Microbiology, Kumamoto University School of Medicine, Japan.

Highly purified cytochrome P-450 reductase (also called cytochrome C reductase; EC 1.6.2.4.) and NADPH were found to generate superoxide radical (O2.-) from 11 different heterocyclic amines (HCAs) as identified by electron spin resonance spectroscopy (ESR) using the spin trapping method with 5,5-dimethyl-1-pyrroline-N-oxide (DMPO). The signal intensity of DMPO-OOH(-O2.-) (i.e., the DMPO spin adduct of O2.-) was strongest for 2-amino-3,4-dimethylimidazo[4,5-f]-quinoline (MeIQ). O2.- generation with HCAs was decreased in the following order: 2-amino-3,8-dimethylimidazo[4,5-f]-quinoxaline (MeIQx) = 2-amino-3-methylimidazo[4,5-fl-quinoline (IQ) > 2-amino-3,4,8-trimethylimidazo[4,5-f]-quinoxaline (diMeIQx) > or = other HCAs; O2.- generation was lowest with 2-amino-3-methyl-9H-pyrido[2,3-b]indole-CH3COOH (MeA alpha C). By using Lineweaver-Burk plots, Km values of cytochrome P-450 reductase for mitomycin C, IQ, and MeIQ were determined to be 1.60 x 10(-6)M, 1.97 x 10(-5)M, and 2.83 x 10(-6) M, respectively. The N-hydroxyl derivative of 3-amino-1-methyl-5H-pyrido[4,3-b]-indole-HCI-CH3COOH (Trp-P-2), which is considered to be a key intermediate in the reaction of Trp-P-2 with cytochrome P-450 systems, yielded very little generation of O2.-. Because of the known presence of cytochrome P-450 reductase in the cell at significant amount, the present findings are an important implication for carcinogenesis and tumor promotion due to the known effect of oxygen radicals on promotion/progression, cell kill and proliferation.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008862 Microsomes, Liver Closed vesicles of fragmented endoplasmic reticulum created when liver cells or tissue are disrupted by homogenization. They may be smooth or rough. Liver Microsomes,Liver Microsome,Microsome, Liver
D009152 Mutagenicity Tests Tests of chemical substances and physical agents for mutagenic potential. They include microbial, insect, mammalian cell, and whole animal tests. Genetic Toxicity Tests,Genotoxicity Tests,Mutagen Screening,Tests, Genetic Toxicity,Toxicity Tests, Genetic,Genetic Toxicity Test,Genotoxicity Test,Mutagen Screenings,Mutagenicity Test,Screening, Mutagen,Screenings, Mutagen,Test, Genotoxicity,Tests, Genotoxicity,Toxicity Test, Genetic
D009153 Mutagens Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. Clastogen,Clastogens,Genotoxin,Genotoxins,Mutagen
D009245 NADH Dehydrogenase A flavoprotein and iron sulfur-containing oxidoreductase that catalyzes the oxidation of NADH to NAD. In eukaryotes the enzyme can be found as a component of mitochondrial electron transport complex I. Under experimental conditions the enzyme can use CYTOCHROME C GROUP as the reducing cofactor. The enzyme was formerly listed as EC 1.6.2.1. NADH Cytochrome c Reductase,Diaphorase (NADH Dehydrogenase),NADH (Acceptor) Oxidoreductase,NADH Cytochrome c Oxidoreductase,Dehydrogenase, NADH
D009249 NADP Nicotinamide adenine dinucleotide phosphate. A coenzyme composed of ribosylnicotinamide 5'-phosphate (NMN) coupled by pyrophosphate linkage to the 5'-phosphate adenosine 2',5'-bisphosphate. It serves as an electron carrier in a number of reactions, being alternately oxidized (NADP+) and reduced (NADPH). (Dorland, 27th ed) Coenzyme II,Nicotinamide-Adenine Dinucleotide Phosphate,Triphosphopyridine Nucleotide,NADPH,Dinucleotide Phosphate, Nicotinamide-Adenine,Nicotinamide Adenine Dinucleotide Phosphate,Nucleotide, Triphosphopyridine,Phosphate, Nicotinamide-Adenine Dinucleotide
D011804 Quinolines
D011810 Quinoxalines Quinoxaline
D002273 Carcinogens Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. Carcinogen,Oncogen,Oncogens,Tumor Initiator,Tumor Initiators,Tumor Promoter,Tumor Promoters,Initiator, Tumor,Initiators, Tumor,Promoter, Tumor,Promoters, Tumor
D003497 Cyclic N-Oxides Heterocyclic compounds in which an oxygen is attached to a cyclic nitrogen. Heterocyclic N-Oxides,Cyclic N Oxides,Heterocyclic N Oxides,N Oxides, Cyclic,N-Oxides, Cyclic,N-Oxides, Heterocyclic,Oxides, Cyclic N

Related Publications

H Maeda, and K Sato, and T Akaike
March 1996, Free radical research,
H Maeda, and K Sato, and T Akaike
May 1988, Bulletin of environmental contamination and toxicology,
H Maeda, and K Sato, and T Akaike
January 1988, Free radical research communications,
H Maeda, and K Sato, and T Akaike
January 1984, Archives of biochemistry and biophysics,
H Maeda, and K Sato, and T Akaike
January 2004, Report on carcinogens : carcinogen profiles,
H Maeda, and K Sato, and T Akaike
January 1995, Princess Takamatsu symposia,
H Maeda, and K Sato, and T Akaike
February 1965, The Journal of organic chemistry,
Copied contents to your clipboard!